Download Edition 10 - Spring - Summer 2003

25 years of
research
The Australian New Zealand Breast Cancer Trials Group (ANZ BCTG)
will this year celebrate 25 years of conducting quality clinical trials
research in Australia and New Zealand.
The ANZ BCTG is one of the oldest and most respected breast cancer
clinical trials groups in the world. Our researchers are dedicated and
highly regarded in the international scientific community for their
expertise and involvement in breast cancer clinical trials research.
Our national clinical trials research program today involves 69 medical
institutions throughout Australia and New Zealand, along with 300
researchers, and collaboration with 15 countries internationally.
The cost to conduct a national clinical trials research program is
substantial and a cause for concern. It is essential for us to ensure
that our data collection and analysis for our research program is of
the highest standard. Infrastructure alone costs more than $1million
per year.
We are fortunate to receive peer reviewed funding from the National
Health and Medical Research Council for some of our research
programs. However, community support and corporate sponsorships
must cover the shortfall to allow us the freedom to conduct our
research program in accord with scientific priorities.
The ANZ BCTG through its high reputation, credibility and resultant
influence on breast cancer practice in Australia is able to identify key
areas for priority in furthering quality research.
contents
2… from John Forbes
3… grassroots advocacy for clinical trials
4… research update
5… profile of a researcher
6-7… kiss goodbye to breast cancer
This includes identifying the importance of tumour tissue collection at
the time of diagnosis as routine standard of care. Collecting and
storing tumour tissue samples will allow testing of tumour tissue to
identify new treatments at the earliest opportunity. Benefits to women
would be immediate, and research which may have taken several
years to complete can be done in a short timeframe.
We are very proud of our reputation and of the research progress
which has been achieved to date through our national clinical trials
research program.
With your support, we look forward to keeping Australia at the
forefront of international research progress. More importantly, you can
help to ensure that more women are cured of breast cancer and that
breast cancer prevention is a reality for all women.
On behalf of our researchers, please accept my sincere thanks for your
ongoing support of our research programs.
8… the toner recycler, tee off
9... 2004 diary
10… successful fundraising, in memoriam
11… meet the BCIA staff, donation slip
12… participating institutions
2
Professor John F. Forbes - National Group Coordinator,
Australian New Zealand Breast Cancer Trials Group.
Medical Director, Breast Cancer Institute of Australia.
grassroots advocacy for
clinical trials
Over the last 25 years, breast cancer clinical trials research has led to many important and
life-saving discoveries for women. But, with almost 400,000 women dying from breast cancer
each year, worldwide, there is still much to be done to create a world without breast cancer.
Clinical trials research has been instrumental in reducing mortality from breast cancer by
providing doctors with clear, scientifically proven advances in breast cancer prevention,
detection and treatment.
Currently in Australia, less than 10% of women who are eligible to participate in a breast cancer
clinical trial actually have the opportunity to take part in one. Advances in breast cancer control
would occur much faster if more women could participate in breast cancer clinical trials
research and if infrastructure funding for clinical trials research is increased. For these things to
occur, the community needs to have an increased awareness about the importance of clinical
trials research and infrastructure funding for this research must increase.
The ANZ BCTG is leading the way in educating the community about the importance of
clinical trials research, through a unique program called IMPACT – Improving Participation
and Advocacy for Clinical Trials. IMPACT is a network of women who have participated in
breast cancer clinical trials coordinated by the ANZ BCTG and who are interested in becoming
consumer advocates for clinical trials research.
IMPACT members are kept informed of the latest advances in breast cancer clinical trials
research and are encouraged to use their personal networks to promote clinical trials
research. Over time, this grassroots advocacy campaign should result in more women
participating in breast cancer clinical trials, increased funding for those trials and ultimately,
faster and more reliable answers to important research questions.
IMPACT currently has over 1,000 members from most states in Australia. Membership of IMPACT
is free and members can choose the level of their participation. IMPACT is generously sponsored
by AVON. Information Sessions for new members have been held in Newcastle, Canberra and
Melbourne and an inaugural Education Workshop was held in Newcastle in 2002.
Involvement in IMPACT is one example of how breast cancer survivors are participating in the
ANZ BCTG’s research effort to prevent and cure breast cancer. Another is through the ANZ BCTG
Consumer Advisory Panel. The Consumer Advisory Panel provides ANZ BCTG researchers with
women’s perspectives on clinical trials issues and also assists in the coordination of the
IMPACT program. Each member of the Consumer Advisory Panel is a breast cancer survivor
who has participated in a breast cancer clinical trial. These women are able to give
ANZ BCTG researchers important feedback in areas such as patient information, quality of
life issues and informing trial participants of trial results.
For more information about IMPACT or the ANZ BCTG Consumer Advisory Panel, please
visit www.bcia.org.au.
3
research
update
Research results published
Breast x-rays (mammograms) can detect very small
Mastectomy (breast removal) was considered to be
areas of calcification in breast ducts, which may be
an over-treatment for these women, however local
a marker of early, pre-invasive breast cancer. This
surgical excision (removal of the lump only) may
form of breast cancer is called DCIS – ductal
not be sufficient treatment. Hence, this trial aimed
carcinoma in situ - and the incidence of DCIS has
to assess the effectiveness of radiotherapy and
increased concurrent with mammography
also tamoxifen as additional treatments after local
screening programs being introduced throughout
surgical excision.
the world.
The results of this trial were recently published in
How to best treat women diagnosed with this type
the medical journal The Lancet on July 12th 2003.
of breast cancer formed the basis of an
The results showed that radiotherapy can be
international clinical trial which began in 1990.
recommended for many patients with DCIS who are
This study was conducted in Australia and New
treated with complete local surgical excision
Zealand by the ANZ BCTG, and also in the United
(removal of the lump). The trial also showed benefit
Kingdom. The total accrual was 1,701 women
for tamoxifen. A similar trial in the US has recently
internationally, with 187 (11%) of these women
showed that the tamoxifen benefit is confined to
from Australia and New Zealand.
women with hormone sensitive DCIS.
New research for
younger women
The ANZ BCTG is conducting new international
suppressed by the chemotherapy, the outcome seems
collaborative research through clinical trials
to be better than when the ovaries continue to
specifically targeted to younger women with
function. Our new research will test strategies to
breast cancer.
suppress high oestrogen levels through ovary
suppression after chemotherapy has been completed.
Women diagnosed with breast cancer before the age
4
of 40 are usually treated only with chemotherapy
This new research has been planned in Australia by
after their surgery. Past research studies of the
the ANZ BCTG and will involve international
ANZ BCTG, in collaboration with international
collaboration from clinical trials groups in both
researchers, have shown that if ovary function is
Europe and North America.
profile of
a researcher
Dianne Lindsay
B. App. Sci. (Cons Sci) Hons.
Head of Data Management, ANZ BCTG
Dianne was first employed by a regional electricity
authority, and later travelled extensively with her
husband through Africa, Britain and Europe,
returning to Australia for the birth of her first child.
She looked after a (then) young family, was a
coordinator for the Safety House program and
became very involved in supporting her children’s
education at their local schools. Her interest in
women’s health began during studies at the Hunter
Institute, NSW where she qualified as a Home
Economist. After returning to further tertiary study
as a mature student she completed an honours
degree in Applied Science (Consumer Science) at the
University of Newcastle, NSW and was an Associate
Lecturer in Nutrition and Dietetics and Consumer
Science at the University prior to her appointment at
the ANZ BCTG Operations Office in 1996.
Her first role with the ANZ BCTG involved clinic data
management and the central coordination of a
number of International Breast Cancer Study Group
(IBCSG) adjuvant clinical trials. A clinic data
manager assists investigators to recruit and enter
patients to clinical trials and is responsible for
scheduling patient follow up and providing support
to these patients during their participation in a
clinical trial.
In 1998 Dianne continued her clinic duties and was
appointed Senior Study Coordinator for IBCSG trials.
This involved coordinating the involvement in these
trials of all participating hospitals outside Victoria,
and liaison with data managers from The Cancer
Council Victoria's Centre for Clinical Research in
Cancer for centres within Victoria. Dianne was
responsible for the involvement of a number of new
centres in these, and other trials, and the transfer of
data collected about trial participants to international
collaborative groups.
In August 2000 Dianne was appointed Head of
Data Management and is now responsible for the
coordination of all the Group's trials, collaboration
with a number of international research groups,
and the supervision of 21 research data managers
and two administrative staff in the ANZ BCTG
Operations Office.
This office coordinates the participation of 69
institutions in Australia and New Zealand in breast
cancer research trials. An important aspect of trial
coordination in the past two years has been the
commencement of three trials researching the
treatment of advanced breast cancer, one of which
involves collaboration, for the first time, with the
Breast Cancer International Research Group (BCIRG)
in Paris, France. Other trials that the data
management team is helping to activate include
three for premenopausal women who are diagnosed
with early breast cancer, and the next generation of
trials investigating the prevention of breast cancer in
post-menopausal women who have been diagnosed
with ductal carcinoma in situ; have a family history
of breast cancer; or have a high risk of developing
this disease due to other reasons.
Dianne enjoys all aspects of her role, especially the
involvement of new institutions in the Group's research
program and visiting institutions to complete audits
of their trial participation. Both her children are now
young adults, her son has recently been awarded an
honours degree in Computer Engineering and her
daughter is completing her degrees in Science and
Mathematics at the University of Newcastle, NSW.
When time permits, Dianne enjoys bushwalking,
reading, gardening and cooking, especially making
home baked bread the old fashioned way. Her only
regret is that there are not enough hours in the day
to do everything she would like to do!
5
A V O N
Kiss Goodbye to Breast Cancer
Avon will again this year conduct its very successful campaign “Kiss Goodbye to Breast Cancer”. Last year,
$100,000 was raised through the sale of special lipsticks for our research programs.
September 15th to 21st is Kiss & Commit Week, when Avon Representatives across Australia and New Zealand
will be out in force, selling “Kiss Goodbye to Breast Cancer” Lipsticks. For every lipstick sold, $1 will be donated
to the Australian New Zealand Breast Cancer Trials Group (ANZ BCTG) for breast cancer research and to the
YWCA Encore Program, an exercise and support program for women who have had breast cancer surgery.
Avon is the world’s leading fundraiser for the breast cancer cause, with an enormous US$250 million raised
to date worldwide. Thanks to the dedication of Avon Representatives in Australia and New Zealand, over
$4 million has already been donated to the ANZ BCTG and YWCA Encore Program through sales of Avon
Pink Ribbon Products.
Specially designed Brilliant Moisture Lipsticks with the Pink Ribbon Motif come in four
unique shades - Crusade Rose, Brave Brocade, Spice of Life and Courageous Coral.
They are available for just $9.95 and each comes with a complimentary “Kiss Goodbye
to Breast Cancer” Mirror Compact.
6
Deborah Hutton
Catriona Rowntree
Jackie O
Susie O’Neill
Gretel Killeen
Natalie Bassingthwaighte
Kate Ceberano
Bridie Carter
Many well known entertainment and sporting celebrities have lent their support to this campaign by
providing their “kiss”. These include:
Sophie Lee, Actor
Susie O’Neill, Olympian
Deborah Hutton, The Australian Women’s Weekly, Ch 9
Wendy Hughes, Actor
Sharyn Ghidella, TODAY, Ch 9
Bridie Carter, McLeod’s Daughters, Ch 9
Karina Brown, TV Presenter
Kylie Ingram, The Block, Ch 9
Mary Coustas, Greeks on the Roof, Ch 7
Kate Ceberano, Entertainer
Maggie Tabberer, Australian Fashion & TV Icon
Gretel Killeen, Author & Big Brother Host, Ch 10
Tara Moss, Best Selling Author
Toni Pearen, Funniest Home Video, Ch 9
Catriona Rowntree, Getaway, Ch 9
Tara Brown, 60 Minutes, Ch 9
Livinia Nixon, Ch 9
Jackie Woodburne, Neighbours, Ch 10
Sami Lukis, TODAY, Ch 9
Suzie Wilks, Changing Rooms, Ch 9
Jacinta Stapleton, Stingers, Ch 9
Natalie Bassingthwaighte, Neighbours, Ch 10
Jackie O, Radio & TV Presenter, 2day FM Sydney
Bridget McIntyre, The Car Show, Ch 9 Melbourne
Avon Pink Ribbon Products are available throughout the year in the Avon Brochure for just $3.95. The Pink
Ribbon Pin is shown above. For more information see your Avon Representative, or call Avon on 1800 646 000.
Livinia Nixon
Sophie Lee
Tara Moss
Karina Brown
Suzie Wilks
Toni Pearen
Wendy Hughes
Sami Lukis
7
The Toner Recycler
supports research
A long-standing BCIA donor has broadened his
support for breast cancer research through the
recycling of toner cartridges.
Daryl Webb has been making regular donations
to the BCIA since 1998 following the death of his
mother from breast cancer in 1997.
Last year, Daryl approached the BCIA with a
proposal to make monthly donations through his
Sydney-based company, The Toner Recycler Pty Ltd.
This company specialises in the collection and
distribution of empty printer and fax toner
cartridges to the toner recycling industry.
Since September 2002, the BCIA has received
$1.00 for every recyclable toner cartridge collected
by The Toner Recycler Pty Ltd. At the time of
going to print, this represents a total of $24,004
received from The Toner Recycler Pty Ltd - a
valuable contribution to breast cancer research.
Daryl and his team of collectors currently operate
in NSW in metropolitan and suburban Sydney,
Canberra, the Central Coast, the Riverina, Griffith,
Wagga Wagga, Port Stephens and Newcastle.
Over 1,000 businesses, including corporate offices,
factories, distribution centres and stationery
wholesalers are utilising the environmentally-based
recycling program offered by The Toner Recycler
Pty Ltd. Daryl expects to be collecting from 2,000
businesses by the end of the year.
We sincerely appreciate the generosity of Daryl
and The Toner Recycler Pty Ltd in supporting the
BCIA and breast cancer research.
For further information on the services offered by The
Toner Recycler Pty Ltd, please phone (02) 9801 8774,
email [email protected], or visit the website
www.tonerrecycler.com.au, or alternatively contact the
BCIA on 1800 423 444.
The team from Toner Recycler Pty Ltd - (from left) Richard Pascoe,
Tony Zonca, Joe Gagliardi and Daryl Webb (Managing Director).
A day for birdies
Over 100 golf clubs throughout Australia have
already registered in the BCIA’s annual charity golf
event, “Tee Off for Breast Cancer Research”. Now in its
sixth year, “Tee Off” (formerly called “Chip In”), has
raised over $270,000 for breast cancer research.
Women’s Golf Clubs throughout Australia are invited
to participate in “Tee Off” by nominating one club
event day as their special day to “Tee Off for Breast
Cancer Research”. Clubs choose their own format for
the event. So far this year, Clubs have held special
8
tournaments, organised raffles, collected fines, and even
held a Tupperware Stall to raise money for the BCIA.
Many of the Golf Clubs that participate in “Tee Off”
each year do so because their own members have
been affected by breast cancer. Raising funds for
breast cancer research is their way of honouring
those who have been affected by the disease.
If you belong to a golf club and wish to
become involved in “Tee Off”, please call us
on 1800 423 444 for an information pack.
2004 diary
on sale now
Following the continued success of our Australian
Women’s Health Diary, we are delighted to
introduce the 2004 edition. It is available from
September 15th in newsagents nationally and from
most Woolworths and Safeway supermarkets.
Our diary has been produced since the 1999
calendar year, and has raised over $1.6 million for
our national breast cancer research programs.
We have freshened up the 2004 diary layout and
design – providing a new, modern look that we
know you will enjoy. It is still a convenient A5
size, with a soft cover and spiral bind which
makes it easy to fit into a handbag or briefcase. It
also has all of the essential diary features such as
adequate space for daily notes, school terms and
public holidays.
Of course, also included is all of the important health
information you have come to expect from the diary.
Health pages include information on skin care,
nutrition and exercise, along with financial,
pregnancy and lifestyle
information.
Designed for women all of ages, this diary is a
“must have”. The feedback we receive from buyers
of the diary is always positive, and the added
bonus is that each diary sold will help us fund
important research for the prevention and cure of
breast cancer.
The diary would not be a success without our major
sponsors. The creative team at The Australian
Women’s Weekly produce the diary on our behalf,
whilst the Commonwealth Bank and Avon help us
to cover the printing and production costs.
We hope to have your support for the diary again
this year. You can purchase your diary for just
$12.95 from newsagents and most Woolworths
and Safeway supermarkets nationally, or call our
order line on 1800 423 444 ($15.95 including
postage and handling).
We are pleased to provide the diary as a complimentary
gift for our donors who donate $55.00 or more.
Just make sure you tick the box on the donation
slip to ensure you receive your diary.
9
successful
fundraising
The BCIA is regularly contacted by individuals, community and corporate
groups wishing to make a contribution to breast cancer research.
Here are some examples of the wonderful support we receive:
Since 1991, Mary Kay Cosmetics has generously donated a total of
$250,000 to the ANZ BCTG for our research programs. These funds
are raised through the sale of “Warm Fuzzies”. Milly Lim, a Mary Kay
Consultant from Chatswood, NSW recently approached a woman for a
gold coin donation for the “Warm Fuzzy” program and was amazed to
receive instead from Mrs Elaine Mah a cheque for $10,000. We are
very grateful for the ongoing support we receive from Mary Kay and to
Mrs Mah for her generosity.
in
memoriam
We gratefully acknowledge gifts received in
memory of:
Ms Edna May Berry
Mrs Christine McBeth
Ms Alice Blance Coyle
Ms Penny McGrath
Mrs Jean Borgelt
Ms Denise Malouf
Mrs Sue Broster
Mrs Marion Marcus
Ms Gayle Marie Campbell
Mrs Hazel Martin
Mrs Robin Clifton
Ms Betty Miemer
Ms Debbie Comerford
Mrs Jill Morris
Mrs Maree Cox
Mrs Filomena Mullins
Ms Christine Eddy
Mrs Pamela New
Mrs Catherine Greig
Ms Robyn Ransome
Mrs Jill James
Miss Michelle Rook
Mrs Veronika Januszke
Mrs Lyndal Sim
Mrs Marion Jefferson
Mrs Eileen Slocumbe
Karen
Mrs Adrienne Smith
Mrs Val Lamb
10
David, who is currently living in London, ran both the London and
Paris marathons on consecutive weekends in April this year to
raise funds for breast cancer research. He dedicated the runs to his
sister-in-law who has been battling breast cancer for the past five
years, and asked his friends and family to support him in his
fundraising efforts.
David received pledges totalling $3,450 for the BCIA. This is a
tremendous effort and David’s thoughtfulness is sincerely appreciated.
When Peter and Melissa from Wodonga in Victoria were planning
their wedding earlier this year, they decided to ask their guests to
make a donation to the BCIA in lieu of giving a wedding gift.
They were delighted with the results.
Through the generosity of their family and friends, Peter and Melissa
donated a total of $1,436 to the BCIA.
“We had the most fantastic, enjoyable and memorable day, and are proud
we could do a little for the Breast Cancer Institute of Australia”, they said.
The Lions Club of Mount Hutton, NSW, with just 14 members,
recently donated $1,500 to local charities in the Newcastle and Lake
Macquarie area. The money was raised from activities conducted
throughout the year, including trivia nights, raffles and bus trips.
The BCIA was one recipient of the club’s fundraising efforts and
received a cheque for $500. We thank them for their hard work
and generosity.
pleased to
meet you
We would like to take this opportunity to introduce the
staff of the Breast Cancer Institute of Australia (BCIA).
Julie Callaghan began working with the ANZ BCTG
in 1992. Following the establishment of the BCIA in
1994, Julie became the Development Manager of the
BCIA in 1995. Julie is responsible for coordinating
the fundraising, education and promotion activities
of the BCIA.
Jenny Sly is the Special Projects Officer – Fundraising
and Promotion. Jenny began work with the BCIA in
April 2000 and is responsible for the BCIA Bequest
Program, Mother‘s Day Promotion, and other major
BCIA fundraising events.
Kelly Wilks is the BCIA Administration Officer and
she began work with the BCIA in April 2000. Kelly
is responsible for coordinating the processing of
donations and managing the BCIA donor database.
Victoria Small is the Special Projects Officer –
Fundraising and Education. Victoria began work
with the BCIA in February this year and is responsible
for the administrative component of the IMPACT
Program, along with other BCIA fundraising events
such as “Tee Off”.
Mylinda Booth is the BCIA Administration Assistant.
Mylinda began work with the BCIA in March this year
and is responsible for processing donations, general
The team from the BCIA: Jenny Sly, Mylinda Booth, Julie
Callaghan, Kelly Wilks and Victoria Small.
administrative duties and will most likely be the
person you first meet on the other end of the phone!
Special thanks to Linda Swain of Cactus Creative Communications and NCP Printing for their support in the production and printing of this newsletter.
how to donate tobreast
cancer research
Yes! I would like to make a contribution to breast cancer research. My cheque/money order for
❏ $30 ❏ $50 ❏ $75 ❏ $100 or $__________ is enclosed, OR please debit my credit card:
❏ Bankcard ❏ Visa ❏ Mastercard Card No.: ____ ____ ____ ____ Expiry date: ____
Name of Cardholder: __________________ Cardholder’s signature: ___________________
Ongoing support
❏
Please charge $___________ to the above credit card monthly until I
advise otherwise. Signature: _____________________________
Mr/Mrs/Dr/Ms/Miss: _____________________________________________________
Address: _______________________________________________________________
State: ______________ Postcode: ____________ Telephone: ______________________
Post to the Breast Cancer Institute of Australia PO Box 283 The Junction, NSW 2291 or fax to (02) 4925 3068
Donations can also be made by phoning: 1800 423 444. Thank You! Your gift is tax deductible.
SPRING 2003
11
list of participating institutions
Women throughout Australia can have access to the latest treatments in the Australian
Board of Directors
New Zealand Breast Cancer Trials Group research program.
Alfred Hospital
Prahran VIC 3181
Ashford Cancer Centre
Ashford SA 5035
Auckland Hospital
New Zealand
Austin Health
Heidelberg VIC 3084
Bankstown-Lidcombe Hospital
Bankstown NSW 2200
Ballarat Oncological Services
Ballarat VIC 3350
The Bendigo Hospital
Bendigo VIC 3550
Satellite Clinics:
Echuca Hospital
Echuca VIC 3564
Kerang Hospital
Kerang VIC 3579
Mildura Base Hospital
Mildura VIC 3500
Border Medical Oncology
Wodonga VIC 3690
Box Hill Hospital
Box Hill VIC 3128
Caboolture Hospital
Caboolture QLD 4510
Cabrini Hospital
Malvern VIC 3144
The Canberra Hospital
Garran ACT 2605
The Cancer Council Victoria
Carlton South VIC 3053
Christchurch Hospital
New Zealand
Christchurch IBIS Centre
New Zealand
Concord Repatriation
General Hospital
Concord NSW 2139
Darwin Private Hospital
Casuarina NT 0810
Dubbo Base Hospital
Dubbo NSW 2830
Dunedin Hospital
New Zealand
Flinders Medical Centre
Bedford Park SA 5042
Frankston Hospital
Frankston VIC 3199
Fremantle Hospital
Fremantle WA 6160
The Geelong Hospital
Geelong VIC 3220
Satellite Clinic:
St John of God Hospital
Warrnambool VIC 3280
The Jean Hailes Foundation
Clayton VIC 3168
Launceston General Hospital
Launceston TAS 7250
Lingard Private Hospital
Merewether NSW 2291
Lismore Base Hospital
Lismore NSW 2480
Liverpool Hospital
Liverpool NSW 2170
Maroondah Hospital
Ringwood East VIC 3135
Mater Hospital
North Sydney NSW 2060
Mater Adult Hospital
South Brisbane QLD 4101
Mater Private Medical Centre
South Brisbane QLD 4101
Mater Private Breast Care Unit
South Brisbane QLD 4101
Mercy Private Hospital
East Melbourne VIC 3002
Monash Breast Service
Clayton VIC 3168
Monash Medical Centre
East Bentleigh VIC 3165
Mount Hospital
Perth WA 6000
NHMRC Clinical Trials Centre
Camperdown NSW 2050
Nepean Cancer Care Centre
Kingswood NSW 2751
Newcastle Mater
Misericordiae Hospital
Waratah NSW 2298
Satellite Clinics:
The Breast Centre
Waratah NSW 2298
Manning Base Hospital
Taree NSW 2430
Muswellbrook Hospital
Muswellbrook NSW 2333
Orange Base Hospital
Orange NSW 2800
Palmerston North Hospital
New Zealand
Peter MacCallum
Cancer Institute
East Melbourne VIC 3002
Port Macquarie Base Hospital
Port Macquarie NSW 2444
Prince of Wales Hospital
Randwick NSW 2031
Princess Alexandra Hospital
Woolloongabba QLD 4102
Queen Elizabeth Hospital
Woodville South SA 5011
Royal Adelaide Hospital
Adelaide SA 5000
Royal Brisbane Hospital
Herston QLD 4006
Royal Hobart Hospital
Hobart TAS 7000
Royal Hospital for Women
Randwick NSW 2031
Royal Melbourne Hospital
Parkville VIC 3052
Royal North Shore Hospital
St Leonards NSW 2065
Royal Perth Hospital
Perth WA 6000
Royal Prince Alfred Hospital
Camperdown NSW 2050
Royal Women’s Hospital
Carlton VIC 3053
St Andrew’s Medical Centre
Adelaide SA 5000
St George Hospital
Kogarah NSW 2217
St John of God Hospital
Geelong VIC 3220
St John of God Hospital
Murdoch WA 6150
St John of God Hospital
Subiaco WA 6008
St Vincent’s Hospital
Darlinghurst NSW 2010
Satellite Clinics:
Griffith Base Hospital
Griffith NSW 2680
Wagga Wagga Base Hospital
Wagga Wagga NSW 2650
St Vincent’s Hospital
Fitzroy VIC 3065
Satellite Clinic:
Goulburn Valley Base Hospital
Shepparton VIC 3630
Sir Charles Gairdner Hospital
Nedlands WA 6009
Tamworth Base Hospital
Tamworth NSW 2340
Tasmanian IBIS Centre
Hobart TAS 7000
Toowoomba Base Hospital
Toowoomba QLD 4350
Townsville General Hospital
Townsville QLD 4810
Waikato Hospital
New Zealand
Wellington Hospital
New Zealand
The Wesley Breast Clinic
Toowong QLD 4066
Wesley Medical Centre
Auchenflower QLD 4066
Western Hospital
Footscray VIC 3011
Westmead Hospital
Westmead NSW 2145
Dr Raymond D Snyder
Board Chairman
St Vincent’s Hospital,
Melbourne
Prof Alan S Coates
Board Vice Chairman
The Cancer Council Australia
Prof John F Forbes
Board Group Coordinator,
Secretary
University of Newcastle
Dr Russell Basser
Director of Clinical Research
CSL Ltd, Melbourne
Dr Fran Boyle
Royal North Shore Hospital,
Sydney
Dr Ian Campbell
Waikato Hospital, NZ
Dr Jacquie Chirgwin
Box Hill & Maroondah
Hospitals, VIC
Dr Geoffrey Lindeman
Walter & Eliza Hall Institute
of Medical Research,
Melbourne
Prof R John Simes
Director, NHMRC Clinical
Trials Centre, Sydney
Editorial Information
Editor:
Julie Callaghan
Development Manager, Breast
Cancer Institute of Australia
Postal Address:
PO Box 283
The Junction, NSW 2291
Phone: (02) 4925 3022
Fax:
(02) 4925 3068
E-mail:
[email protected]
If you would like information
on making a bequest, or
would like to be removed
from our mailing list, please
contact us on the details
shown above.
ABN
CFN
CCP
ATO
64 051 369 496
10881
923
N0939